Position in CPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$11,023,523
+$2,939,294 QoQ
Shares Held
445,215
+28.5% QoQ
Ownership
0.364%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE GROUP LLC holds $57,437,743 across 5 Biotechnology names. CPRX ranks #2 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
471,499 | $30,472,980 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
445,215 | $11,023,523 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
51,168 | $9,673,310 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
642,535 | $5,789,240 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,072 | $478,690 |
All Filings in CPRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,023,523 | 445,215 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,084,229 | 346,368 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $7,013,633 | 356,022 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $7,140,536 | 329,057 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $6,117,911 | 252,285 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,231,601 | 202,760 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||